Teva Pharmaceutical Industries Limited: shareholders and insiders

TEVANYSEHealthcare · Pharmaceutical Preparations

Price

$42.62

November 17, 2026Market cap $49.0B

What Ploutos Investor adds for Teva Pharmaceutical Industries

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • Most of the reported profit is a tax credit, not money earned from customers. We leave out the P/E and the earnings growth, which would not compare with a company that paid tax.

Insiders and their shares

Purchases and sales by officers and directors from Nov 18, 2025 to Nov 17, 2026, from their own Form 4 filings.

39 Form 4s

Bought on the market

–

nobody

Sold on the market

$125M

15 people

From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan63%
  • The rest37%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $111M by 15 people

  • 2025: no buys, sold $14M by 5 people
  • 2026: no buys, sold $111M by 15 people
  • Nov 15, 2026Dov BergwerkInterim Chief Legal Officer
    Kind
  • Nov 12, 2026Mark SabagSee "Remarks"
    Kind
  • Nov 12, 2026Mark SabagSee "Remarks"
    Kind
  • Nov 11, 2026Richard DaniellEVP, Europe Commercial
    Kind
  • Nov 11, 2026Richard DaniellEVP, Europe Commercial
    Kind
  • Nov 10, 2026Richard D FrancisPresident and CEO
    Kind10b5-1
  • Nov 9, 2026Richard DaniellEVP, Europe Commercial
    Kind
  • Nov 9, 2026Richard DaniellEVP, Europe Commercial
    Kind
  • Nov 9, 2026Amir WeissChief Accounting Officer
    Kind
  • Nov 9, 2026Amir WeissChief Accounting Officer
    Kind
  • Nov 9, 2026Amir WeissChief Accounting Officer
    Kind
  • Nov 9, 2026Amir WeissChief Accounting Officer
    Kind
  • Nov 5, 2026Mark SabagSee "Remarks"
    Kind
  • Nov 5, 2026Mark SabagSee "Remarks"
    Kind
  • Nov 4, 2026Dov BergwerkInterim Cheif Legal Officer
    Kind
  • Nov 4, 2026Dov BergwerkInterim Cheif Legal Officer
    Kind
  • Nov 4, 2026Dov BergwerkInterim Cheif Legal Officer
    Kind
  • Nov 4, 2026Dov BergwerkInterim Cheif Legal Officer
    Kind
  • Sep 18, 2026Brian SavageInterim Chief Legal Officer
    Kind
  • Sep 18, 2026Brian SavageInterim Chief Legal Officer
    Kind
  • Sep 18, 2026Brian SavageInterim Chief Legal Officer
    Kind
  • Sep 18, 2026Brian SavageInterim Chief Legal Officer
    Kind
  • Sep 18, 2026Roberto MignoneDirector
    Kind
  • Aug 21, 2026Amir WeissChief Accounting Officer
    Kind
  • Aug 21, 2026Amir WeissChief Accounting Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 1, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by TEVA's officers and directors from 2018 up to November 17, 2025, 8 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%Nov 10, 2026 Latest filing
  • Harel Insurance Investments & Financial Services Ltd.
    Share of class6.00%
  • Migdal Insurance & Financial Holdings Ltd
    Share of class5.37%
  • Phoenix Financial Ltd.
    Share of class5.00%
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Menora Mivtachim Holdings4.99%Nov 10, 202613G/A
  • FMR2.10%Nov 5, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

No well-known manager

None of the managers we track held Teva Pharmaceutical Industries shares in their latest 13F.

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 2.44% of its shares outstanding were held short, -6.0% since the report before.

Shares held short
28.07M
2.44%
Since the report before29.85M on Sep 30, 2026
-6.0%
3.9
7.16M
More days to cover thanof 4,578 US-listed companies with enough volume
47%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 17.49M
  • Nov 15, 2023: Shares held short 14.18M
  • Nov 30, 2023: Shares held short 13.31M
  • Dec 15, 2023: Shares held short 14.12M
  • Dec 29, 2023: Shares held short 16.35M
  • Jan 12, 2024: Shares held short 16.76M
  • Jan 31, 2024: Shares held short 18.32M
  • Feb 15, 2024: Shares held short 15.39M
  • Feb 29, 2024: Shares held short 14.72M
  • Mar 15, 2024: Shares held short 10.46M
  • Mar 28, 2024: Shares held short 11.56M
  • Apr 15, 2024: Shares held short 11.66M
  • Apr 30, 2024: Shares held short 12.22M
  • May 15, 2024: Shares held short 13.00M
  • May 31, 2024: Shares held short 18.08M
  • Jun 14, 2024: Shares held short 24.56M
  • Jun 28, 2024: Shares held short 22.31M
  • Jul 15, 2024: Shares held short 17.68M
  • Jul 31, 2024: Shares held short 19.50M
  • Aug 15, 2024: Shares held short 23.99M
  • Aug 30, 2024: Shares held short 23.95M
  • Sep 13, 2024: Shares held short 30.34M
  • Sep 30, 2024: Shares held short 24.49M
  • Oct 15, 2024: Shares held short 19.91M
  • Oct 31, 2024: Shares held short 18.09M
  • Nov 15, 2024: Shares held short 21.19M
  • Nov 29, 2024: Shares held short 22.41M
  • Dec 13, 2024: Shares held short 23.22M
  • Dec 31, 2024: Shares held short 27.13M
  • Jan 15, 2025: Shares held short 15.80M
  • Jan 31, 2025: Shares held short 22.36M
  • Feb 14, 2025: Shares held short 26.66M
  • Feb 28, 2025: Shares held short 27.81M
  • Mar 14, 2025: Shares held short 34.80M
  • Mar 31, 2025: Shares held short 32.39M
  • Apr 15, 2025: Shares held short 30.34M
  • Apr 30, 2025: Shares held short 28.43M
  • May 15, 2025: Shares held short 38.70M
  • May 30, 2025: Shares held short 35.67M
  • Jun 13, 2025: Shares held short 40.00M
  • Jun 30, 2025: Shares held short 39.87M
  • Jul 15, 2025: Shares held short 53.42M
  • Jul 31, 2025: Shares held short 49.89M
  • Aug 15, 2025: Shares held short 46.26M
  • Aug 29, 2025: Shares held short 50.51M
  • Sep 15, 2025: Shares held short 55.19M
  • Sep 30, 2025: Shares held short 49.88M
  • Oct 15, 2025: Shares held short 47.28M
  • Oct 31, 2025: Shares held short 50.39M
  • Nov 14, 2025: Shares held short 46.44M
  • Nov 28, 2025: Shares held short 45.62M
  • Dec 15, 2025: Shares held short 44.94M
  • Dec 31, 2025: Shares held short 32.86M
  • Jan 15, 2026: Shares held short 32.97M
  • Jan 30, 2026: Shares held short 37.95M
  • Feb 13, 2026: Shares held short 36.64M
  • Feb 27, 2026: Shares held short 32.53M
  • Mar 13, 2026: Shares held short 37.62M
  • Mar 31, 2026: Shares held short 27.04M
  • Apr 15, 2026: Shares held short 29.74M
  • Apr 30, 2026: Shares held short 31.14M
  • May 15, 2026: Shares held short 26.65M
  • May 29, 2026: Shares held short 33.87M
  • Jun 15, 2026: Shares held short 33.35M
  • Jun 30, 2026: Shares held short 32.03M
  • Jul 15, 2026: Shares held short 32.74M
  • Jul 31, 2026: Shares held short 34.32M
  • Aug 14, 2026: Shares held short 35.67M
  • Aug 31, 2026: Shares held short 37.61M
  • Sep 15, 2026: Shares held short 31.48M
  • Sep 30, 2026: Shares held short 29.85M
  • Oct 15, 2026: Shares held short 28.07M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading26.0% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 26.0% of the shares in the reported trades were short sales, against 35.9% in the 14 before.

Last 14 sessionsOct 29, 2026 – Nov 17, 2026
26.0%
The 14 beforeOct 9, 2026 – Oct 28, 2026
35.9%
Change
-9.9 pts
Short sales a dayon average, of 3.43M shares
893.0K
More than atof 3,666 US-listed companies, same days
2%
Median of alleight in ten from 34.6% to 63.7%
50.3%
  • Oct 9, 2026: Short sales 36.2%
  • Oct 12, 2026: Short sales 45.6%
  • Oct 13, 2026: Short sales 43.3%
  • Oct 14, 2026: Short sales 41.9%
  • Oct 15, 2026: Short sales 34.8%
  • Oct 16, 2026: Short sales 33.2%
  • Oct 19, 2026: Short sales 44.5%
  • Oct 20, 2026: Short sales 37.7%
  • Oct 21, 2026: Short sales 43.9%
  • Oct 22, 2026: Short sales 31.7%
  • Oct 23, 2026: Short sales 15.2%
  • Oct 26, 2026: Short sales 18.2%
  • Oct 27, 2026: Short sales 23.4%
  • Oct 28, 2026: Short sales 39%
  • Oct 29, 2026: Short sales 26.2%
  • Oct 30, 2026: Short sales 30%
  • Nov 2, 2026: Short sales 45%
  • Nov 3, 2026: Short sales 36%
  • Nov 4, 2026: Short sales 30.8%
  • Nov 5, 2026: Short sales 15.2%
  • Nov 6, 2026: Short sales 28%
  • Nov 9, 2026: Short sales 30.4%
  • Nov 10, 2026: Short sales 15.2%
  • Nov 11, 2026: Short sales 18.5%
  • Nov 12, 2026: Short sales 19.2%
  • Nov 13, 2026: Short sales 25.7%
  • Nov 16, 2026: Short sales 32.8%
  • Nov 17, 2026: Short sales 18.4%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

4.60M Insiders' shares0.40% Of the company
  • Amir ElsteinDirector
    Directly2.12M
  • Richard D FrancisPresident and CEO
    Directly927.5K
  • Sol J BarerDirector
    Directly448.0K
  • Eric A HughesSee "Remarks"
    Directly134.9K
  • Gerald M LiebermanDirector
    Directly130.1K
  • Rosemary A CraneDirector
    Directly127.7K
  • Roberto MignoneDirector
    Directly119.8K
  • Perry NisenDirector
    Directly119.8K
  • Ronit Satchi-FainaroDirector
    Directly112.0K
  • Mark SabagSee "Remarks"
    Directly80.8K
  • Tal Zvi ZaksDirector
    Directly73.2K
  • Eliyahu Sharon KalifEVP, Chief Financial Officer
    Directly65.6K
  • Richard DaniellEVP, Europe Commercial
    Directly55.8K
  • Evan LippmanEVP, Business Development
    Directly25.6K
  • Dov BergwerkInterim Chief Legal Officer
    Directly20.3K
  • Chen LichtensteinDirector
    Directly19.3K
  • Brian SavageInterim Chief Legal Officer
    Directly8,500
  • Placid JoverSee "Remarks"
    Directly6,774
  • Amir WeissChief Accounting Officer
    Directly3,537
  • Matthew ShieldsEVP, Global Operations
    Directly–

A lower bound: it counts only the 20 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

14 ETFs holding it3.06% The largest weight (PPH)
  • PPHVanEck Pharmaceutical ETF
    Weight in the fund3.06%
  • IDMOInvesco S&P International Developed Momentum ETF
    Weight in the fund0.50%
  • DBEFXtrackers MSCI EAFE Hedged Equity ETF
    Weight in the fund0.19%
  • SCHFSchwab International Equity ETF
    Weight in the fund0.14%
  • FNDFSchwab Fundamental International Equity ETF
    Weight in the fund0.13%
  • VEAVanguard Developed Markets Index Fund
    Weight in the fund0.12%
  • SPDWState Street(R) SPDR(R) Portfolio Developed World ex-US ETF
    Weight in the fund0.11%
  • VEUVanguard Ftse All-World Ex-Us Index Fund
    Weight in the fund0.10%
  • VXUSVanguard Total International Stock Index Fund
    Weight in the fund0.09%
  • AVDEAvantis International Equity ETF
    Weight in the fund0.09%

14 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

673 Managers, Q2 2026$24.8B Value of their positions
  • Q3 2025: Managers 554
  • Q4 2025: Managers 632
  • Q1 2026: Managers 656
  • Q2 2026: Managers 673

Institutional investors by quarter

The fund managers holding TEVA, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 673 managers held 737M shares, worth $24.8B. During the quarter 82 opened a position, 66 closed one, 272 added and 192 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter-1.9%
  • Harel Insurance Investments & Financial Services
    In the quarter+4.7%
  • Phoenix Financial
    In the quarter+0.4%
  • Wcm Investment Management
    In the quarter+1.2%
  • Clal Insurance Enterprises Holdings
    In the quarter+5.6%
  • Menora Mivtachim Holdings
    In the quarter+0.6%
  • Migdal Insurance & Financial Holdings
    In the quarter+2.7%
  • Norges Bank
    In the quarter-8.2%
  • FMR
    In the quarter-8.7%
  • Lingotto Investment Management
    In the quarter-27%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Teva Pharmaceutical Industries's filings show?

Who buys and sells is one part of Teva Pharmaceutical Industries's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about TEVA's shareholders

Didn't find what you were looking for?

Ask us
Have TEVA's insiders bought or sold?

From Jun 1, 2026 to Nov 17, 2026 Teva Pharmaceutical Industries's insiders bought 0 and sold $40M of shares on the market. 42% of the sales were under set 10b5-1 plans.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.